Rachel Hopkins, MD
Basic profileRachel Hopkins is an Endocrinology/Metabolic physician affiliated with SUNY Upstate Medical University. OpenAlex indexes 15 publications with 436 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20241 payment$135
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
35.7%l-Thyroxine28.2%Levothyroxine Sodium86%Synthroid14%Part D<11 patientsVasopressin Analog3.5%Desmopressin Acetate100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
25.3%GLP-1 receptor agonist11.9%Ozempic66%Trulicity34%Part D≥13 patientsInsulin Analog5.6%Novolog Flexpen100%Part D≥13 patients+ 2 more classes in this area
Sensory organs
17.3%Corticosteroid17.3%Hydrocortisone88%Dexamethasone Sodium Phosphate12%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Using Stakeholder Input to Develop a Best Practice Advisory (BPA) to Increase Prescribing of Automated Insulin Delivery (AID) Systems for People With Type 1 Diabetes (PwT1D)
Journal of Diabetes Science and Technology
2026 - Insulin edema after initiation of hybrid closed-loop insulin pump therapy with continuous glucose monitoring: a case report
Clinical Diabetes and Endocrinology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Jeffrey Ross, MD
SUNY Upstate Medical University
Andras Perl, MD
SUNY Upstate Medical University
Ruth Weinstock, MD
SUNY Upstate Medical University
Jade Homsi, MD
SUNY Upstate Medical University
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”